Bhubaneswar: The Institute of Life Science (ILS), Bhubaneswar, has been chosen as one of the 16 biorepository centres in the country for COVID-19 clinical samples.
The government of India is looking to increase research and development efforts in order to create new diagnostics, therapeutics and vaccines in the future. The repository will collect, store and maintain clinical samples (oropharyngeal/nasopharyngeal swabs, bronchoalveolar lavage, sputum, blood, urine and stool) of coronavirus patients.
The institute will be authorized to share these samples with academia, industry and commercial entities involved in development of diagnostics, therapeutics, vaccines after scrutinization. The purpose of sharing clinical specimens and the intended use will be examined by the National Oversight Committee as well as the Institutional Human Ethics Committee.
Puri: A miscreant was nabbed and handed over to police by local people while he…
By Darpan Bhalla The phenomenon of climate change has made a profound and multifaceted impact on farming,…
Bhubaneswar: In order to clear additional rush of passengers in regular trains, the East Coast…
Gajapati: A five-year-old girl, who was severely injured after she fell into a cauldron containing…
Bhubaneswar: NCC cadets and NSS volunteers of Siksha ‘O’ Anusandhan Deemed to be University (SOA)…
New Delhi: Aravani, or the Koovagam Festival, an annual gathering of transgender community was held…
Bhubaneswar: Even as intensity of heatwave came down in several places of Odisha with 8…
Bhubaneswar: Chief Minister Naveen Patnaik will kick off his election campaign for the upcoming Lok…